Cargando…
Alzheimer’s Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian Cohort of Geriatric Outpatients: A Retrospective Cross-sectional Study
BACKGROUND: The role of cerebrospinal fluid (CSF) biomarkers, and neuroimaging in the diagnostic process of Alzheimer’s disease (AD) is not clear, in particular in the older patients. OBJECTIVE: The aim of this study was to compare the clinical diagnosis of AD with CSF biomarkers and with cerebrovas...
Autores principales: | Dolci, Giulia A. M., Damanti, Sarah, Scortichini, Valeria, Galli, Alessandro, Rossi, Paolo D., Abbate, Carlo, Arosio, Beatrice, Mari, Daniela, Arighi, Andrea, Fumagalli, Giorgio G., Scarpini, Elio, Inglese, Silvia, Marcucci, Maura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702632/ https://www.ncbi.nlm.nih.gov/pubmed/29214153 http://dx.doi.org/10.3389/fmed.2017.00203 |
Ejemplares similares
-
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation
por: Arighi, Andrea, et al.
Publicado: (2022) -
Cerebrospinal fluid glutamate changes in functional movement disorders
por: Demartini, Benedetta, et al.
Publicado: (2020) -
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease
por: Arcaro, Marina, et al.
Publicado: (2022) -
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic
por: Sacchi, Luca, et al.
Publicado: (2023) -
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters
por: Arighi, Andrea, et al.
Publicado: (2021)